BMB-201

N/A

Report date: 2025/01/22 15:22:25
NME

Base Information

Drug NameBMB-201
Drug Alias NameBMB-201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor agonistsSerotonin 2c (5-HT2c) receptor agonists
TargetsSerotonin 2a (5-HT2a) receptorSerotonin 2c (5-HT2c) receptor
Therapy Area/IndicationsDepressive Disorder, Treatment-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBright Minds Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesBright Minds Biosciences Inc
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Treatment-Resistant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A